The CD47 Targeting Therapeutics Market Forecast suggests promising future opportunities in the field of immuno-oncology. As cancer remains one of the leading causes of mortality worldwide, researchers are exploring innovative therapies that harness the body’s immune system to fight tumors. CD47 inhibitors are designed to enhance immune cell activity by preventing cancer cells from hiding...
English